The present report describes a novel application of [TIMP-2] [IGFBP7]/1000, known as Nephrocheck®, a rapid urine-based diagnostic method that has already been incorporated into clinical practice to identify an AKI biomarker within critical care because it is simple to collect and may be used sequentially or in a monitoring context. This evidence concerns the gene IGFBP7 and acute kidney injury.